for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

GlaxoSmithKline plc

GSK.L

Latest Trade

1,678.00GBp

Change

11.00(+0.66%)

Volume

6,703,491

Today's Range

1,667.60

 - 

1,688.20

52 Week Range

1,485.20

 - 

1,857.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
1,667.00
Open
1,669.80
Volume
6,703,491
3M AVG Volume
146.64
Today's High
1,688.20
Today's Low
1,667.60
52 Week High
1,857.00
52 Week Low
1,485.20
Shares Out (MIL)
5,016.41
Market Cap (MIL)
83,623.61
Forward P/E
--
Dividend (Yield %)
--

Next Event

Dividend For GSK.L - 23.0000 GBX

Latest Developments

更多

FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process

GlaxoSmithKline Expects 2020 Adj EPS To Fall; Plans To Split Into Two Cos

GSK Says EMA Accepted Marketing Application For Multiple Myeloma Drug

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About GlaxoSmithKline plc

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.

Contact Info

G S K House, 980 Great West Road

+44.20.80475000

https://www.gsk.com/

Executive Leadership

Jonathan Richard Symonds

Independent Non-Executive Chairman of the Board

Emma N. Walmsley

Chief Executive Officer, Executive Director

Iain James Mackay

Chief Financial Officer, Executive Director

Roger G. Connor

President - Vaccines

Brian McNamara

Chief Executive Officer - GSK Consumer Healthcare

Key Stats

2.58 mean rating - 26 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2017

30.2K

2018

30.8K

2019

33.8K

2020(E)

35.0K
EPS (GBp)

2017

111.800

2018

119.400

2019

123.900

2020(E)

116.736
Price To Earnings (TTM)
17.95
Price To Sales (TTM)
2.48
Price To Book (MRQ)
6.94
Price To Cash Flow (TTM)
10.12
Total Debt To Equity (MRQ)
254.57
LT Debt To Equity (MRQ)
196.85
Return on Investment (TTM)
12.32
Return on Equity (TTM)
7.65

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up